Checkpoint immunotherapy rejects primary tumors without cDC1 cells or lasting immune memory
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
Tag: T cell activation in immunotherapy
PR2 Immunotherapy Shows Promise in DLBCL Cases
In a remarkable advance within the realm of immunotherapy, a new study published in the journal "Annals of Hematology" sheds ...
Bioorthogonal Nanoparticles Enhance T Cell Tumor Response
In a groundbreaking study, researchers have harnessed the potential of bioorthogonal chemistry to develop tumour-specific proteolysis-targeting chimeras (PROTACs) and nanoparticles ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!